Health
Fluvoxamine may prevent serious illness in COVID-19 patients – China.org.cn
CHICAGO, Nov. 13 (Xinhua) — Researchers at Washington University School of Medicine in St. Louis have found in a preliminary study that the drug fluvoxamine seems to prevent some of the most serious complications of COVID-19 patients and make hospitalization and the need for supplemental oxygen less likely.
In an innovative twist to research during the pandemic, the study, involving 152 patients infected with SAR-CoV-2, the virus that causes COVID-19, was conducted remotely. When a symptomatic…
-
Noosa News14 hours agoBiodiversity at Bowra | Noosa Today
-
General23 hours agoA-League Men live: City holds upper hand against Victory in grand final
-
General5 hours agoSocceroos name 26-man squad for World Cup qualifier against Japan in Perth
-
Noosa News8 hours agoElderly motorcyclist dies following collision with truck at Wynnum in Brisbane’s east